Related references
Note: Only part of the references are listed.Changes in multiple sclerosis symptoms are associated with changes in work productivity of people living with multiple sclerosis
Barnabas Bessing et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Averting multiple sclerosis long-term societal and healthcare costs: The Value of Treatment (VoT) project
Michela Tinelli et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Diagnosis -specific sickness absence and disability pension before and after multiple sclerosis diagnosis: An 8-year nationwide longitudinal cohort study with matched references
Chantelle Murley et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Types of working-life sequences among people recently diagnosed with multiple sclerosis in Sweden: a nationwide register-based cohort study
Chantelle Murley et al.
BMJ OPEN (2020)
Importance of early treatment decisions on future income of multiple sclerosis patients
Andrius Kavaliunas et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2020)
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden
Korinna Karampampa et al.
PHARMACOECONOMICS-OPEN (2020)
Estimating Health Cost Repartition Among Diseases in the Presence of Multimorbidity
Valentin Rousson et al.
HEALTH SERVICES RESEARCH AND MANAGERIAL EPIDEMIOLOGY (2019)
The long-term impact of early treatment of multiple sclerosis on the risk of disability pension
Erik Landfeldt et al.
JOURNAL OF NEUROLOGY (2018)
Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
Joao J. Cerqueira et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System
Nicole L. Pratt et al.
BMJ OPEN (2018)
Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group
Peter Rieckmann et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age
Hanna Gyllensten et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2018)
Importance of early treatment initiation in the clinical course of multiple sclerosis
Andrius Kavaliunas et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Importance of early treatment initiation in the clinical course of multiple sclerosis
Andrius Kavaliunas et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Registers of the Swedish total population and their use in medical research
Jonas F. Ludvigsson et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2016)
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools
Christian D. E. Collins et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Rituximab in multiple sclerosis A retrospective observational study on safety and efficacy
Jonatan Salzer et al.
NEUROLOGY (2016)
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools
Christian D. E. Collins et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Cost of Illness of Multiple Sclerosis - A Systematic Review
Olivia Ernstsson et al.
PLOS ONE (2016)
The Swedish MS registry - clinical support tool and scientific resource
J. Hillert et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
T test as a parametric statistic
Tae Kyun Kim
KOREAN JOURNAL OF ANESTHESIOLOGY (2015)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Effect of Treatment with Natalizumab on Ability to Work in People with Multiple Sclerosis Productivity Gain Based on Direct Measurement of Work Capacity before and after 1 Year of Treatment
Sara Olofsson et al.
BIODRUGS (2011)
Potential Health Care Cost Savings Associated With Early Treatment of Multiple Sclerosis Using Disease-Modifying Therapy
Suellen M. Curkendall et al.
CLINICAL THERAPEUTICS (2011)
Swedish natalizumab (Tysabri) multiple sclerosis surveillance study
Fredrik Piehl et al.
NEUROLOGICAL SCIENCES (2011)
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Ranjan Dutta et al.
PROGRESS IN NEUROBIOLOGY (2011)
Share Paper
